Replies to post #9479 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

It's a pleasant surprise that implies the collaboration is producing results ahead of schedule. I wasn't expecting BAX to exercise the option on compounds #3-#6 until 2013 at the earliest (although I noted in #msg-78079512 that it could happen at any time).